Endoscopic submucosal dissection versus surgery for undifferentiated-type early gastric cancer: A meta-analysis.

Authors

null

Byung-Wook Kim

Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea, Republic of (South)

Byung-Wook Kim , Dae Won Ma , Joon Sung Kim

Organizations

Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea, Republic of (South), Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Korea, Republic of (South), Department of Internal Medicine, College of Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Korea, Republic of (South)

Research Funding

Other Foundation

Background: It is still controversial to treat undifferentiated early gastric cancer by endoscopic submucosal dissection (ESD). Therefore, we aimed to perform a meta-analysis to investigate long-term outcomes of ESD and surgery for undifferentiated early gastric cancer. Methods: PubMed, Cochran Library, and EMBASE were used to search for relevant researches comparing endoscopic submucosal dissection and surgery for undifferentiated early gastric cancer. The methodological quality of the included publications was evaluated using the Risk of Bias Assessment tool for Non-randomized Studies. The overall survival rate, recurrence rate, adverse event rate, and complete resection rate were explored, and the odds ratio (OR) and 95% confidence interval (CI) were estimated. Results: This meta-analysis enrolled five studies, with 376 and 1148 participants undergoing ESD and surgery, respectively. Overall survival rate did not show significant difference between ESD and surgery group (OR 0.57, 95% CI 0.18 – 1.83, P = 0.34). However, ESD was associated with higher recurrence rate (OR 11.57, 95% CI 5.07 – 26.39, P< 0.001) and lower complete resection rate (OR 0.03, 95% CI 0.01 – 0.11, P< 0.001). Adverse event rate was similar between two groups (OR 0.95, 95% CI 0.46 – 1.96, P = 0.88). Conclusions: Despite higher recurrence rate and lower complete resection rate, ESD demonstrated similar overall survival rate and adverse event rate in the treatment of undifferentiated early gastric cancer compared to surgery.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 111)

DOI

10.1200/JCO.2019.37.4_suppl.111

Abstract #

111

Poster Bd #

K3

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Gastric microbiome signature to predict metachronous recurrence after endoscopic resection of gastric neoplasms.

First Author: Hokyoung Lee

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Impact of DNA mismatch repair status on prognosis of patients with locally advanced gastric cancer in a Mexican population.

First Author: Maria del Consuelo Diaz Romero

Abstract

2016 Gastrointestinal Cancers Symposium

Survival benefit of additional surgery after non-curative endoscopic resection in patients with early gastric cancer.

First Author: Keun Won Ryu